Clinical Trials Logo

Femoral Artery Stenosis clinical trials

View clinical trials related to Femoral Artery Stenosis.

Filter by:

NCT ID: NCT05734157 Active, not recruiting - Clinical trials for Femoral Artery Occlusion

CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Proximal Popliteal Artery

Start date: February 17, 2022
Phase: N/A
Study type: Interventional

The CVT-SFA Trial investigates the inhibition of restenosis using the CVT Everolimus-coated PTA Catheter in the treatment of de-novo occluded/ stenotic or re-occluded/restenotic superficial femoral or popliteal arteries.

NCT ID: NCT05608655 Completed - Clinical trials for Popliteal Artery Stenosis

DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis

DELTA
Start date: December 27, 2022
Phase: N/A
Study type: Interventional

A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy and Safety of DKutting Balloon Versus Chocolate Balloon in the Treatment of Femoral and Popliteal Artery Stenosis

NCT ID: NCT05117515 Enrolling by invitation - Clinical trials for Carotid Artery Stenosis

Retrospective Study of the Uni-Graft® K DV Patch in the Clinical Routine

RESTUGPA
Start date: April 27, 2022
Phase:
Study type: Observational

Uni-Graft® K DV Patch is marketed in Europe since 1999 for reconstructive interventions of the deep femoral, femoral and iliac artery and was also indicated for carotid interventions until 01/2020. Previous studies focused on the clinical performance of different patch materials used for patch angioplasty in different indications, without specifying the product or manufacturer. Thus, it is not surprising that there is a limited amount of published literature available describing the use of the Uni-Graft® K DV Patch in the clinical routine. Therefore, the aim of the present non-interventional study (NIS) is to close this gap by collecting and evaluating existing safety and performance data documented in the clinical routine especially during the application of the Uni-Graft® K DV Patch.

NCT ID: NCT04343196 Completed - Clinical trials for Peripheral Arterial Disease

Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction

Start date: April 21, 2020
Phase: N/A
Study type: Interventional

Digital Variance Angiography (DVA) is a new tool in medical imaging with proven image quality reserve. The previously observed quality reserve of Digital Variance Angiography (DVA) in lower extremity angiographies, allowed to lower radiation exposure by 70 % during DSA in lower extremity diagnostic angiographies with non-inferior image quality. The aim of this study is to apply this non-inferior image quality and use it for radiation exposure reduction in diagnostic lower limb angiography. The project would prospectively block-randomise (50:50) patients, who undergo elective diagnostic angiography into two groups: a comparator group examined by means of conventional DSA using a standard care protocol (Siemens Artis Zee, Extremities Care setting, 1.2 µGy/frame) (Group B) and a study group examined by means of DVA using a low-dose protocol (0.36 µGy/frame corresponding to 70% decrease of radiation dose) (Group A). During each procedure the investigators record radiation exposure (cumulative dosage, dose area product) and contrast media usage and procedural time then compare the results of the groups. Qualitative image review is done to compare conventional DSA and reduced radiation exposure DVA images after image acquisition. Our hypothesis is that with the previously proven non-inferior image quality, the investigators will be able to reduce radiation exposure of the participants and also staff members in everyday clinical practice.

NCT ID: NCT03844724 Completed - Clinical trials for Peripheral Arterial Disease

Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion

Start date: April 10, 2015
Phase: N/A
Study type: Interventional

Clinical study on safety and efficacy of ZENFlow™ drug-eluting PTA balloon dilatation catheter in the treatment of iliac, femoral and popliteal artery stenosis or occlusion

NCT ID: NCT03687983 Recruiting - Clinical trials for Femoral Artery Occlusion

Safety and Efficacy Study of GoldenFlow Peripheral Stent System

Start date: May 11, 2016
Phase: N/A
Study type: Interventional

A Prospective, Multi-center, Single-Arm Clinical Trial to evaluate the safety and efficacy of the GodenFlow Peripheral Stent System manufactured by Lifetech Scientific (Shenzhen) Co., LTD. for lower limb artery stenosis or occlusion diseases.

NCT ID: NCT03683459 Recruiting - Clinical trials for Femoral Artery Occlusion

Safety and Efficacy Study of FemFlow Drug-Eluting Peripheral Balloon Catheter

Start date: July 18, 2018
Phase: N/A
Study type: Interventional

A prospective, multi-centre, objective performance criteria clinical trial to evaluate the safety and efficacy of FemFlow Drug-Eluting Peripheral Balloon Catheter manufactured by Lifetech Scientific (Shenzhen) Co., LTD. for lesions with femoropopliteal artery stenosis or occlusion.

NCT ID: NCT02813577 Terminated - Clinical trials for Femoral Artery Occlusion

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)

CONFIRM
Start date: April 20, 2018
Phase: N/A
Study type: Interventional

The post approval study will enroll US female patients presenting with claudication or ischemic rest pain and an angiographically significant lesion in the superficial femoral or popliteal artery. Subjects are treated per Instructions For Use (IFU) with the Lutonix® Catheter. Subjects will have a Duplex Ultrasound (DUS) and clinical follow-up through two (2) years.

NCT ID: NCT02720003 Completed - Clinical trials for Femoral Artery Occlusion

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

Start date: March 2016
Phase: N/A
Study type: Interventional

To assess the safety and efficacy of the BARD LTX DCB for treatment of stenosis or occlusion of the superficial femoral and popliteal arteries.

NCT ID: NCT02063672 Completed - Restenosis Clinical Trials

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

SFA ISR
Start date: March 2014
Phase: N/A
Study type: Interventional

To assess the safety and efficacy of the Lutonix Drug Coated Balloon for treatment of femoropopliteal artery (SFA) in-stent restenosis (ISR).